40 results on '"Danø K"'
Search Results
2. Systemic administration of anti‐urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue‐type plasminogen activator deficient mice
3. ID: 262 Inhibition of mouse uPA activity by mouse monoclonal antibodies
4. ID: 257 Cleavage of uPAR; mechanism and prognostic significance.
5. ID: 261 Generation and characterization of murine monoclonal antibodies against murine uPAR
6. 754 Role of plasminogen activation system
7. 106 Association of preoperative plasma PAI-1 and CRP levels in patients with colorectal cancer
8. 68 Impairment of post-lactational involution of the mammary gland in mice deficient for the plasminogen gene
9. Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients
10. Urokinase and urokinase receptor expression in somatic cell hybrids
11. The murine urokinase-type plasminogen activator receptor gene
12. Urokinase-type receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies
13. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion
14. Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins
15. Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation.
16. Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin.
17. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.
18. Expression of type IV collagenases in invasive tumors
19. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
20. Diversity in catalytic properties of single chain and two chain tissue-type plasminogen activator
21. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor
22. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
23. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells.
24. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
25. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
26. Localization of urokinase-type plasminogen activator receptor on U937 cells: Phorbol ester PMA induces heterogeneity
27. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.
28. One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity.
29. The phorbol ester, PMA, increases cellular levels of mRNA coding for plasminogen activator inhibitor type-1 (PAI-1) in human neoplastic cells
30. Interaction of Plasminogen Activator Inhibitor (PAI-1) with Vitronectin
31. Inactive zymogen forms of plasminogen activators from human neoplastic cells
32. Type-1 plasminogen activator inhibitor (PAI-1): Cell-specific expression and hormonal regulation in human cell lines
33. Molecular studies of the cellular receptor for urokinase-type plasminogen activator
34. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
35. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme
36. Purification and characterization of a plasminogen activator from mouse cells transformed by an oncogenic virus
37. Transforming growth factor-beta induces incresed level of plasminogen activator inhibitor mRNA in human lung fibroblasts
38. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
39. Urokinase-type plasminogen activator in plasma from breast cancer patients
40. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.